Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Dahan Michel Insider Profile
4 Followers
Dahan Michel, SVP, Chief Operating Officer at Akebia Therapeutics, holds 269.51K shares in Akebia Therapeutics (Ticker: AKBA). Most recently, Dahan Michel Sold $20,412 shares of Akebia Therapeutics on Mar 03, 2023 for an estimated value of 17.76K.
Dahan Michel Akebia Therapeutics (AKBA)SVP, Chief Operating Officer
Akebia Therapeutics (AKBA)
SVP, Chief Operating Officer
Ranked #34,039 out of 102,868 Corporate Insiders
Profitable Transactions
7 out of 11 Profitable Transactions
Average Return
+2.70%
Average return per transaction
Time Frame
Compare to
Insider Roles
SVP, Chief Operating Officer
Roles that Dahan Michel holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Apr 01, 2021 - Apr 01, 2022
Return:+79.90%
The most profitable trade made by Dahan Michel
Dahan Michel's Trading History
List of latest transactions for each holding click on a transaction to see Dahan Michel's performance on stock
You May Also Like
Dahan Michel insider profile FAQ
What is the percentage of profitable transactions made by Dahan Michel?
The percentage of profitable transactions made by Dahan Michel is 64%.
What is the average return per transaction made by Dahan Michel?
The average return per transaction made by Dahan Michel is 2.70%.
What stocks does Dahan Michel hold?
Dahan Michel holds: AKBA stocks.
What was Dahan Michel’s latest transaction?
Dahan Michel latest transaction was an Informative Sell of $17.76K.
What was Dahan Michel's most profitable transaction?
Dahan Michel’s most profitable transaction was an Informative Sell of AKBA stock on April 1, 2021. The return on the trade was 79.90%.
What is Dahan Michel's role in Akebia Therapeutics?
Dahan Michel's role in Akebia Therapeutics is SVP, Chief Operating Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.